Protein-based nanocarriers in the management of hard-to-treat solid tumours
{{output}}
Despite a steady decline in overall cancer mortality, the survival rates of certain hard-to-treat cancers of the lung, liver, oesophagus, pancreas, and brain remain strikingly low. A key unmet need in this field is the development of effective systemic therapi... ...
